Download PDF
Dtsch Med Wochenschr 2013; 138(34/35): 1729-1733
DOI: 10.1055/s-0033-1343335
Aktuelle Diagnostik & Therapie | Review article
Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Sepsisprävention nach Splenektomie

Prevention of sepsis after splenectomy
C. Theilacker
1   Zentrum für Infektiologie und Reisemedizin, Universitätsklinik Freiburg
,
W. V. Kern
1   Zentrum für Infektiologie und Reisemedizin, Universitätsklinik Freiburg
› Author Affiliations
Further Information

Publication History

24 April 2013

08 July 2013

Publication Date:
09 August 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Splenektomie - Sepsis - Pneumokokken - Prävention - Impfungen

Keywords

splenectomy - sepsis - pneumococcus - prevention - vaccination
 

  • Literatur

  • 1 Berner R, Müller C, Belard S. Epidemiologie und Therapie invasiver Meningokokken-Infektionen. Klin Padiatr 2010; 222: HV_40
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Bisharat N, Omari H, Lavi I et al. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186
    CrossrefPubMedGoogle Scholar
  • 3 Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61: 816-819
    PubMedGoogle Scholar
  • 4 Cherif H, Landgren O, Konradsen HB et al. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006; 24: 75-81
    CrossrefPubMedGoogle Scholar
  • 5 Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA 2013; 309: 275-282
    CrossrefPubMedGoogle Scholar
  • 6 Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
    CrossrefPubMedGoogle Scholar
  • 7 Dendle C, Sundararajan V, Spelman T et al. Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria. Med J Aust 2012; 196: 582-586
    PubMedGoogle Scholar
  • 8 Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378: 86-97
    CrossrefPubMedGoogle Scholar
  • 9 Ejstrud P, Kristensen B, Hansen JB et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 2000; 32: 521-525
    CrossrefPubMedGoogle Scholar
  • 10 Engelhardt M, Eber SW, Germing U et al. Prävention von Infektionen und Thrombosen nach Splenektomie oder funktioneller Asplenie. http://www.dgho-onkopedia.de/de/onkopedia/leitlinien/praevention-von-infektionen-und-thrombosen-nach . Letzter Zugriff: 26.06.2013
    Google Scholar
  • 11 European medicines agency. European Medicines Agency recommends approval of first vaccine for meningitis B [Internet]. Available from: 2012. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/11/news_detail_001656.jsp&mid=WC0b01ac058004d5c1 Letzter Zugriff: 26.6.2013
    Google Scholar
  • 12 Gaston MH, Verter JI, Woods G et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986; 314: 1593-1599
    CrossrefPubMedGoogle Scholar
  • 13 Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001; 4: 105-121
    CrossrefPubMedGoogle Scholar
  • 14 Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78: 1031-1038
    CrossrefPubMedGoogle Scholar
  • 15 Joseph JT, Roy SS, Shams N et al. Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis 2011; 17: 843-847
    CrossrefPubMedGoogle Scholar
  • 16 Kang Y-S, Do Y, Lee H-K et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006; 125: 47-58
    CrossrefPubMedGoogle Scholar
  • 17 King H, Shumaker HB. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 1952; 136: 239-242
    CrossrefPubMedGoogle Scholar
  • 18 Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596
    CrossrefPubMedGoogle Scholar
  • 19 Kyaw MH, Holmes EM, Toolis F et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119: 276.e1-7
    PubMedGoogle Scholar
  • 20 Lammers AJ, de Porto AP, Florquin S et al. Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule. Immunobiology 2011; 216: 863-870
    CrossrefPubMedGoogle Scholar
  • 21 Lee LH, Frasch CE, Falk LA et al. Correlates of immunity for pneumococcal conjugate vaccines. Vaccine 2003; 21: 2190-2196
    CrossrefPubMedGoogle Scholar
  • 22 Mahlaoui N, Minard-Colin V, Picard C et al. Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases. J Pediatr 2011; 158: 142-148
    PubMedGoogle Scholar
  • 23 Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606-616
    CrossrefPubMedGoogle Scholar
  • 24 Mühlemann K. Prävention schwerer Infektionen bei anatomischer oder funktioneller Asplenie. Bull BAG 2006; 49: 977-983
    PubMedGoogle Scholar
  • 25 Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?. Clin Infect Dis 2011; 52: 633-640
    CrossrefPubMedGoogle Scholar
  • 26 Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis 1996; 23: 71-75
    CrossrefPubMedGoogle Scholar
  • 27 Rehnberg M, Amu S, Tarkowski A et al. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther 2009; 11: R123
    CrossrefPubMedGoogle Scholar
  • 28 Rehnberg M, Brisslert M, Amu S et al. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. Arthritis Res Ther 2010; 12: R111
    CrossrefPubMedGoogle Scholar
  • 29 Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect Dis 2010; 10: 112-124
    CrossrefPubMedGoogle Scholar
  • 30 Schwartz PE, Sterioff S, Mucha P et al. Postsplenectomy sepsis and mortality in adults. JAMA 1982; 248: 2279-2283
    CrossrefPubMedGoogle Scholar
  • 31 Shatz DV, Schinsky MF, Pais LB et al. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998; 44: 760-765
    CrossrefPubMedGoogle Scholar
  • 32 Thomsen RW, Schoonen WM, Farkas DK et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med 2009; 151: 546-555
    CrossrefPubMedGoogle Scholar
  • 33 Van Der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556
    CrossrefPubMedGoogle Scholar
  • 34 Vesikari T, Esposito S, Prymula R et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013; 381: 825-835
    CrossrefPubMedGoogle Scholar
  • 35 Weinberger DM, Harboe ZB, Sanders EAM et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699
    CrossrefPubMedGoogle Scholar
  • 36 Robert Koch-Institut. Impfungen bei Asplenie (Entfernung der Milz oder Ausfall der Organfunktion). http://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_ImpfGesundheitsschaden/FAQ01.html . Letzter Zugriff: 3.7.2013
    Google Scholar